News Sentiment

IART sentiment intelligence

Integra LifeSciences Holdings news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 56 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 17.58 Week of 19 Jun 2026
Weighted tone 56/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-1.1% over one week, +16.4% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Integra (IART) Shows Fast-paced Momentum But Is Still a Bargain Stock

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction -1.1% Price digesting
Trend fit Trend active 16.4% over four weeks
Fair value -26.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 42
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 14
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
Stock Titan 10
simplywall.st 5
Investing.com 4
TradingKey 4
AD HOC NEWS 2
GuruFocus 2
GlobeNewswire 2

Event Lens

What the news is about

Classified themes
Earnings 27
Market update 26
Analyst action 6
Regulatory and legal 1
Deals and strategy 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 63
AD HOC NEWS Direct company coverage

Integra LifeSciences Stock - Sunday background on risks and outlook

This article provides a Sunday background look at Integra LifeSciences (IART) stock, focusing on its business profile, key risks, and future outlook. It highlights past quality control issues, current valuation, and earnings expectations, noting that investors are watching remedi

Tone
Neutral 50/100
Event
Earnings
Published
21 Jun 2026 18:10
Source
AD HOC NEWS
Investing.com Direct company coverage

Argus upgrades Integra LifeSciences stock rating on turnaround

Argus has upgraded Integra LifeSciences Holdings (NASDAQ:IART) to Buy from Hold, setting a price target of $25.00 due to expected earnings turnaround driven by executive changes and resolution of production issues. The medical technology company exceeded Q1 EPS expectations and r

Tone
Positive 81/100
Event
Earnings
Published
18 Jun 2026 20:39
Source
Investing.com
Investing.com Canada Direct company coverage

Argus upgrades Integra LifeSciences stock rating on turnaround By Investing.com

Argus has upgraded Integra LifeSciences Holdings (NASDAQ:IART) stock rating to Buy from Hold, setting a price target of $25.00. The upgrade is attributed to executive changes, resolved production issues, and an expected earnings turnaround, along with consistent growth. Integra L

Tone
Positive 72/100
Event
Analyst action
Published
18 Jun 2026 13:09
Source
Investing.com Canada
TradingKey Direct company coverage

Integra Lifesciences Holdings Corp (IART) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey

This article provides a detailed revenue breakdown for Integra Lifesciences Holdings Corp (IART) by business segment and geographical region. It shows that Neurosurgery accounts for over 50% of its revenue, and the United States contributes the largest share regionally. The data

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 00:41
Source
TradingKey
TradingKey Direct company coverage

Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Integra Lifesciences Holdings Corp (IART), listing its major institutional holders and their respective proportions. It also presents a breakdown of shareholder types, including investment advisors, hedge funds, and individual inv

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 21:41
Source
TradingKey
TradingKey Direct company coverage

Integra Lifesciences Holdings Corp (IART) Earnings Forecast: Future EPS & Revenue Growth Estimates

Integra Lifesciences Holdings Corp (IART) has an earnings forecast score of 5.80, ranking 185 out of 203 in its industry. Analysts have set an average price target of $13.00, with a range from $10.00 to $25.00, and a general "Hold" rating. The company's expected revenue for the n

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 12:40
Source
TradingKey
TradingKey Direct company coverage

Integra Lifesciences Holdings Corp (IART) Institutional Confidence

Integra Lifesciences Holdings Corp (IART) has an institutional shareholding score of 10.00, ranking 1st in the Healthcare Equipment & Supplies industry. Institutional holdings increased by 10.94% quarter-over-quarter, with 106.43% of shares held by institutions. ETHSX is the larg

Tone
Positive 71/100
Event
Market update
Published
16 Jun 2026 19:40
Source
TradingKey
Market source Direct company coverage

Integra LifeSciences Holdings Corporation (IART) Hits Fresh High: Is There Still Room to Run?

Integra LifeSciences Holdings Corporation (IART) has recently reached a new 52-week high, with its stock up 23.7% in the past month and 40.6% year-to-date. The company has consistently beaten earnings estimates, reporting EPS of $0.54 against a consensus of $0.41 in its last repo

Tone
Positive 73/100
Event
Earnings
Published
16 Jun 2026 13:39
Source
Market source
Market source Direct company coverage

Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference

Integra LifeSciences Holdings Corporation announced that Bob Davis, executive vice president and president of Tissue Reconstruction, will present at the 2026 Truist Securities MedTech Conference on June 16, 2026, at 3:00 PM ET. A live webcast of the presentation will be available

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 19:10
Source
Market source
Stock Titan Direct company coverage

Live webcast of Integra Truist MedTech talk set for June 16

Integra LifeSciences (Nasdaq: IART) announced that Bob Davis, executive vice president and president Tissue Reconstruction, will present at the 2026 Truist Securities MedTech Conference on June 16, 2026, at 3:00pm ET. A live webcast of the presentation will be available on the co

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 12:40
Source
Stock Titan
Investing.com Direct company coverage

Integra LifeSciences stock hits 52-week high at 17.84 USD

Integra LifeSciences Holdings (IART) stock has reached a 52-week high at $17.84, driven by impressive year-to-date gains of 36.39% and strong first-quarter 2026 financial results that surpassed analyst expectations. The company reported adjusted earnings per share of $0.54 and re

Tone
Positive 70/100
Event
Earnings
Published
09 Jun 2026 15:11
Source
Investing.com
Stock Titan Direct company coverage

Integra (IART) EVP awarded RSUs and stock options in new grant

Michael J. McBreen, EVP & Chief Commercial Officer at Integra LifeSciences Holdings Corp (IART), was granted 31,909 restricted stock units and a non-qualified stock option for 60,372 shares with an exercise price of $15.67. Both awards vest in three equal annual installments, con

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

Integra (IART) CEO receives new RSU and stock option grants

Integra LifeSciences Holdings Corp (IART) CEO Stuart Essig was granted 365,297 Restricted Stock Units (RSUs) and 705,468 non-qualified stock options on June 1, 2026. These awards, part of his employment agreement and at the discretion of the Compensation Committee, will vest over

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 21:09
Source
Stock Titan
TMX Newsfile Direct company coverage

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Integra LifeSciences (IART) Investors of Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm's Attorneys

Hagens Berman is reminding investors of Integra LifeSciences Holdings Corp. (NASDAQ: IART) about a pending securities fraud class action lawsuit. The lawsuit alleges that Integra made misleading statements and failed to disclose Good Manufacturing Practices violations at its Bost

Tone
Negative 8/100
Event
Regulatory and legal
Published
02 Jun 2026 13:40
Source
TMX Newsfile
Stock Titan Direct company coverage

CFO Lea Knight to speak June 3 at Jefferies healthcare forum

Integra LifeSciences announced that its Chief Financial Officer, Lea Knight, will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026, at 10:30 AM ET. A live webcast of the presentation will be available on the company's investor relations website. This pre

Tone
Neutral 50/100
Event
Market update
Published
02 Jun 2026 11:09
Source
Stock Titan
GlobeNewswire Direct company coverage

Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

Integra LifeSciences Holdings Corporation announced that CFO Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026, at 10:30 a.m. ET. A live webcast of the presentation will be available on the company's investor relations website. The company

Tone
Neutral 50/100
Event
Market update
Published
02 Jun 2026 07:30
Source
GlobeNewswire
Markets Mojo Direct company coverage

Integra LifeSciences Hits New 52-Week High at $16.62

Integra LifeSciences Holdings Corp. reached a new 52-week high of $16.62 on May 28, 2026, despite a significant 46.3% decline in its stock performance over the past year. The company, which operates in the Pharmaceuticals & Biotechnology sector, has a market capitalization of $74

Tone
Positive 63/100
Event
Market update
Published
31 May 2026 19:10
Source
Markets Mojo
Markets Mojo Direct company coverage

Integra LifeSciences Hits Day High with 8.36% Surge in Stock Price

Integra LifeSciences Holdings Corp. experienced an 8.36% surge in its stock price, reaching an intraday high of USD 16.62. The company has shown significant short-term growth, with a 53.26% increase over the past month and 32.53% year-to-date, outperforming the S&P 500. Despite t

Tone
Positive 72/100
Event
Market update
Published
29 May 2026 19:39
Source
Markets Mojo
GuruFocus Direct company coverage

IART Upgraded by Citigroup -- Price Target Raised to $16.00

Citigroup has upgraded Integra Lifesciences (IART) from Sell to Neutral, raising its price target to $16.00. While GuruFocus indicates the stock is undervalued by 30.8% with a GF Value of $23.74, its GF Score of 64/100 reveals mixed performance, with strengths in profitability bu

Tone
Positive 71/100
Event
Analyst action
Published
28 May 2026 21:09
Source
GuruFocus